Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach. | Cancers (Basel) | 2022 | 35205782 | PubTator, text mining | PubMed |
| Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells. | Cancers (Basel) | 2022 | 35205738 | PubTator, text mining | PubMed |
| USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets. | Biomedicines | 2022 | 35203682 | PubTator, text mining | PubMed |
| Comprehensive characterization of the epigenetic landscape in Multiple Myeloma. | Theranostics | 2022 | 35198065 | PubTator, text mining | PubMed |
| Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma. | Nat Commun | 2022 | 35197447 | PubTator, text mining | PubMed |
| Cereblon contributes to cardiac dysfunction by degrading Cav1.2α. | Eur Heart J | 2022 | 35190817 | PubTator, text mining | PubMed |
| Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation. | Adv Sci (Weinh) | 2022 | 35187863 | PubTator, text mining | PubMed |
| FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma. | Mol Oncol | 2022 | 35182012 | PubTator, text mining | PubMed |
| Follicular Lymphoma: a Focus on Current and Emerging Therapies | Oncology (Williston Park) | 2022 | 35180337 | PubTator, text mining | PubMed |
| Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study. | Lupus Sci Med | 2022 | 35169036 | PubTator, text mining | PubMed |
| Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary. | Molecules | 2022 | 35164129 | PubTator, text mining | PubMed |
| HDAC Inhibitors: Innovative Strategies for Their Design and Applications. | Molecules | 2022 | 35163980 | PubTator, text mining | PubMed |
| Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. | Cancers (Basel) | 2022 | 35158934 | PubTator, text mining | PubMed |
| Caveolae-Associated Molecules, Tumor Stroma, and Cancer Drug Resistance: Current Findings and Future Perspectives. | Cancers (Basel) | 2022 | 35158857 | PubTator, text mining | PubMed |
| Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions. | Front Pharmacol | 2022 | 35153791 | PubTator, text mining | PubMed |
| Establishment of a developmental toxicity assay based on human iPSC reporter to detect FGF signal disruption. | iScience | 2022 | 35146387 | PubTator, text mining | PubMed |
| Defining molecular glues with a dual-nanobody cannabidiol sensor. | Nat Commun | 2022 | 35145136 | PubTator, text mining | PubMed |
| DNA repair, recombination, and damage signaling. | Genetics | 2022 | 35137093 | PubTator, text mining | PubMed |
| Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models. | Arch Pharm (Weinheim) | 2022 | 35128717 | PubTator, text mining | PubMed |
| [Gene Mutation and Overexpression of Newly Diagnosed Multiple Myeloma Patients]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 | 35123621 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=65